Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-02 Sale | 2025-05-02 6:18 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 6,198 | $11.33 | $70,243 | 33,724 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,377 | $11.5 | $38,841 | 109,137 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 2,894 | $11.5 | $33,286 | 81,091 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,438 | $11.5 | $28,041 | 86,581 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 5:29 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 5,825 | $14.49 | $84,388 | 33,724 (Direct) | View |
| 2025-01-31 Sale | 2025-02-03 8:03 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $19.95 | $114,934 | 86,301 (Direct) | View |
| 2025-01-30 Sale | 2025-01-30 7:53 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,220 | $19.85 | $63,929 | 83,985 (Direct) | View |
| 2025-01-30 Sale | 2025-01-30 7:48 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,690 | $19.85 | $73,260 | 112,514 (Direct) | View |
| 2025-01-30 Sale | 2025-01-30 7:43 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,811 | $19.85 | $55,809 | 94,844 (Direct) | View |
| 2025-01-02 Sale | 2025-01-02 5:28 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $19.5 | $112,295 | 82,070 (Direct) | View |
| 2024-12-02 Sale | 2024-12-02 6:00 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $21.73 | $125,155 | 87,830 (Direct) | View |
| 2024-11-04 Sale | 2024-11-04 5:48 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $25 | $82,250 | 124,473 (Direct) | View |
| 2024-11-01 Sale | 2024-11-01 5:57 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $24.28 | $139,867 | 93,590 (Direct) | View |
| 2024-11-01 Sale | 2024-11-01 5:57 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,546 | $24.28 | $86,083 | 33,724 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,368 | $24.3 | $57,554 | 101,201 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,437 | $24.3 | $83,536 | 116,204 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,182 | $24.3 | $101,644 | 87,205 (Direct) | View |
| 2024-10-14 Sale | 2024-10-15 09:16 am | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $25 | $82,250 | 124,271 (Direct) | View |
| 2024-10-01 Sale | 2024-10-01 7:36 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $22.23 | $128,017 | 95,858 (Direct) | View |
| 2024-09-03 Sale | 2024-09-03 5:33 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,050 | $24.94 | $225,736 | 204,587 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 6:23 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,870 | $25.01 | $246,843 | 136,388 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 5:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,000 | $25.22 | $504,370 | 31,002 (Direct) | View |
| 2024-08-01 Sale | 2024-08-01 7:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,477 | $21.45 | $74,576 | 51,002 (Direct) | View |
| 2024-08-01 Sale | 2024-08-01 7:06 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $21.43 | $123,459 | 107,378 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,956 | $0 | 109,137 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 81,091 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 86,581 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-13 4:09 pm | N/A 2035-03-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2025-03-13 4:07 pm | N/A 2033-04-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 0 | $0 | 10,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:12 pm | N/A 2035-02-10 | Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:12 pm | N/A 2035-02-10 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 109,300 | $0 | 109,300 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:12 pm | N/A 2035-02-10 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 109,300 | $0 | 109,300 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:11 pm | N/A 2035-02-10 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 109,300 | $0 | 109,300 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-03 8:03 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 86,301 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-03 8:03 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 86,301 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-30 7:53 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 83,985 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-30 7:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,957 | $0 | 112,514 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-30 7:43 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 94,844 (Direct) | View |
| 2025-01-02 Exercise | 2025-01-02 5:28 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 82,070 (Direct) | View |
| 2025-01-02 Exercise | 2025-01-02 5:28 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 82,070 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-02 6:00 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 87,830 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-02 6:00 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 87,830 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-04 5:48 pm | N/A 2030-05-27 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $0 | 124,473 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-04 5:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 124,473 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-01 5:57 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 93,590 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-01 5:57 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 93,590 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 101,201 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,957 | $0 | 116,204 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 87,205 (Direct) | View |
| 2024-10-15 Option Award | 2024-10-16 4:48 pm | N/A 2034-10-14 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 09:16 am | N/A 2030-05-27 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $0 | 124,271 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 09:16 am | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 124,271 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-01 7:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 95,858 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-01 7:36 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 95,858 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 204,587 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,050 | $0 | 204,587 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 204,587 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,463 | $1.86 | 136,388 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A 2029-11-13 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,870 | $0 | 136,388 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,407 | $9.57 | 136,388 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-01 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 107,378 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-01 7:06 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 107,378 (Direct) | View |